Olympia Pharmaceuticals Purchases 55,000 Sq Ft Facility in Florida
29 oct. 2024 09h00 HE
|
Olympia Pharmaceuticals
ORLANDO, Fla., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals, a state-of-the-art, FDA 503B pharmaceutical outsourcing facility and 503A pharmacy, today announced it has purchased a...
[Latest] Global Pharmacy Management System Market Size/Share Worth USD 156.6 Billion by 2032 at a 10.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
27 nov. 2023 23h30 HE
|
Custom Market Insights
Austin, TX, USA, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Pharmacy Management System Market Size, Trends and Insights By Solution Type...
Plastic Compounding Market Value Predicted To Reach US$ 95,425.3 Million By 2026 Covering Covid-19 Impact: Acumen Research and Consulting
29 juin 2021 10h35 HE
|
Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Plastic Compounding Market– Global Industry Analysis, Market Size, Opportunities...
CAPS® Expands National Footprint, Opens New 503B Compounding Outsourcing Facility in Phoenix
04 déc. 2018 10h57 HE
|
CAPS, a B. Braun Medical Inc. company
IRVINE, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Central Admixture Pharmacy Services, Inc. (CAPS), a B. Braun company and the nation’s largest network of outsourcing admixture pharmacies, has today...
Earth Science Tech, Inc. Shares Achievements & Updates on it’s Cannabis CBD-Based Nutraceutical Patent Compounding
02 mai 2017 07h45 HE
|
Earth Science Tech, Inc.
Hollywood, May 02, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST), an innovative biotech company focused on cannabis CBD-based (industrial hemp), cannabinoid research and...
Standards for Compounding Sterile Preparations Go Under Major Revision
28 sept. 2015 16h14 HE
|
United States Pharmacopeia
General Chapter <797> is pre-posted for public comment
ROCKVILLE , MD., Sept. 28, 2015 (GLOBE NEWSWIRE) -- The U.S. Pharmacopeial Convention (USP) pre-posted General Chapter 797...
BioCorRx, Inc. Finalizes Asset Purchase Agreement to Acquire Naltrexone Implant Formula for Treating Addiction
07 juil. 2015 08h00 HE
|
BioCorRx
Los Angeles, July 7, 2015 (GLOBE NEWSWIRE) -- BioCorRx, Inc. (BICX), developer of the Start Fresh Program® used for the treatment of alcohol and opioid dependence, announces the finalization of...
BioCorRx, Inc. Announces Reinstatement of Letter of Understanding to Acquire Naltrexone Implant Formula for Treating Addiction
18 mars 2015 08h00 HE
|
BioCorRx
Los Angeles, March 18, 2015 (GLOBE NEWSWIRE) -- BioCorRx, Inc.
(BICX), developer of the Start Fresh Program® used for the
treatment of alcohol and opioid dependence, announces the
reinstatement...
digiMedical Solutions, Inc. Signs Contract to Implement .Net-Based Digital Prescription Software and Call Center Services for Dr. Geoffrey Colino
02 juil. 2008 09h47 HE
|
digiMedical Solutions, Inc.
COLLEYVILLE, TX--(Marketwire - July 2, 2008) - digiMedical Solutions, Inc. (PINKSHEETS: DGMS) announced today that the Company has signed a contract with Dr.
Geoffrey Colino in Bonita Springs,...
digiMedical Solutions, Inc. Signs Letter of Intent With Guardian Health Systems in Support of $10 Million 2008 Revenue Goal
15 mai 2008 12h45 HE
|
digiMedical Solutions, Inc.
DALLAS, TX--(Marketwire - May 15, 2008) - digiMedical Solutions, Inc. (PINKSHEETS: DGMS)
today announced the Company has signed a non-binding letter of intent (LOI)
with Guardian Health Systems. The...